EBITDA: Income before interest, taxes, depreciation and amortization.
Core Laboratories Inc. (CLB) had EBITDA of $5.65M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$121.80M |
|
$-0.79M |
|
$102.07M |
|
$19.72M |
|
$119.91M |
|
$1.89M |
|
$-2.89M |
|
$-1.00M |
|
$-1.00M |
|
$-0.75M |
|
$-0.75M |
|
$-0.75M |
|
$-0.75M |
|
$1.89M |
|
|
EBITDA |
$5.65M |
46.07M |
|
46.07M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$214.37M |
|
$99.98M |
|
$373.36M |
|
$587.73M |
|
$104.73M |
|
$114.46M |
|
$207.85M |
|
$312.58M |
|
$275.14M |
|
$162.46M |
|
$275.14M |
|
46.05M |
|
| Cash Flow Statement Financials | |
$3.96M |
|
$-3.39M |
|
$-0.46M |
|
$22.70M |
|
$22.82M |
|
$0.12M |
|
$5.03M |
|
$-0.46M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.05 |
|
-- |
|
-- |
|
0.29 |
|
0.42 |
|
16.19% |
|
1.55% |
|
1.55% |
|
-- |
|
-0.82% |
|
-0.65% |
|
$0.56M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
1.77 |
|
1.06 |
|
85.12 |
|
-0.27% |
|
-0.46% |
|
-0.13% |
|
-0.19% |
|
$5.98 |
|
$0.01 |
|
$0.09 |
|